FDA announces new qualified health claims for omega-3s and heart disease
The U.S. Food and Drug Administration (FDA) has announced that it does not intend to object to the use of certain qualified health claims stating that consuming eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) omega-3 fatty acids in food or dietary supplements may reduce the risk of hypertension and coronary heart disease.
Top